RESEARCHDIAGNOSTICSTRANSLATIONOUTREACH
 
Paper Detail
C
IF
Pereira SS, Monteiro MP, Costa MM, Ferreira J, Alves MG, Oliveira PF, Jarak I, Pignatelli D
MAPK/ERK pathway inhibition is a promising treatment target for adrenocortical tumors. Journal of cellular biochemistry 120: 894-906, 2019.  [Article] 
 doi: 10.1002/jcb.27451 PMID: 30256438.
 
19
4.2
@ 2014 Ipatimup Institute of Molecular Pathology and Immunology of the University of Porto
A
A
A

Send Email
From
To
Subject